• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别胶质瘤手术前后的血清内脂素水平。

Serum endocan levels before and after surgery on low-grade gliomas.

作者信息

Tanriverdi Taner, Kemerdere Rahsan, Inal Berrin B, Yuksel Odhan, Emre Humeyra O, Ahmedov Merdin, Baran Oguz, Ates Seda

机构信息

Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Clinical Biochemistry Laboratory, Haseki Training and Research Hospital, Istanbul, Turkey.

出版信息

Surg Neurol Int. 2017 Mar 14;8:32. doi: 10.4103/sni.sni_405_16. eCollection 2017.

DOI:10.4103/sni.sni_405_16
PMID:28458946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5369254/
Abstract

BACKGROUND

Endocan has been shown to be a marker for several cancers and may show degree of malignancy. The aim of this study is to assess serum levels of endocan before and after surgery on low-grade gliomas (LGGs).

METHODS

Endocan was assayed by commercially available enzyme-linked immunosorbent assay (ELISA) kits in a total of 19 patients and 12 controls. Serial serum samples were obtained before and after surgery (1 day, 1 week, and 1 month of surgery). Control samples were collected from cord blood during cesarean section. The results were compared with control brain tissues.

RESULTS

Controls showed significantly lower serum endocan levels compared to before and after surgery ( < 0.05). There is a trend of increase in mean serum levels from before surgery and during the very early period after surgery (during first week); however, in the first month, mean serum levels became lower.

CONCLUSION

Endocan, a vital molecule for angiogenesis, is highly expressed before and after surgery in LGGs, but long-term data is needed. Furthermore, future studies should include high-grade gliomas to discuss whether endocan is associated with recurrence and response to treatment.

摘要

背景

内皮糖蛋白已被证明是几种癌症的标志物,可能显示恶性程度。本研究的目的是评估低级别胶质瘤(LGG)手术前后血清内皮糖蛋白水平。

方法

采用市售酶联免疫吸附测定(ELISA)试剂盒对19例患者和12例对照者进行内皮糖蛋白检测。在手术前后(术后1天、1周和1个月)采集系列血清样本。对照样本取自剖宫产术中的脐血。将结果与对照脑组织进行比较。

结果

与手术前后相比,对照者血清内皮糖蛋白水平显著降低(<0.05)。从手术前到术后早期(第一周),平均血清水平有升高趋势;然而,在第一个月,平均血清水平降低。

结论

内皮糖蛋白是血管生成的重要分子,在LGG手术前后高度表达,但需要长期数据。此外,未来的研究应纳入高级别胶质瘤,以探讨内皮糖蛋白是否与复发及治疗反应相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2062/5369254/0ec9f8898235/SNI-8-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2062/5369254/0ec9f8898235/SNI-8-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2062/5369254/0ec9f8898235/SNI-8-32-g003.jpg

相似文献

1
Serum endocan levels before and after surgery on low-grade gliomas.低级别胶质瘤手术前后的血清内脂素水平。
Surg Neurol Int. 2017 Mar 14;8:32. doi: 10.4103/sni.sni_405_16. eCollection 2017.
2
Expressions of Endocan in Patients with Meningiomas and Gliomas.内皮抑素在脑膜瘤和胶质瘤患者中的表达。
Dis Markers. 2016;2016:7157039. doi: 10.1155/2016/7157039. Epub 2016 Jul 27.
3
Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study.血清内皮特异性分子-1(ESM-1/Endocan)水平升高与原发性膀胱癌不良病理结局相关:一项非随机、前瞻性、病例对照研究。
Arch Esp Urol. 2023 Mar;76(2):132-138. doi: 10.56434/j.arch.esp.urol.20237602.14.
4
Endocan expression and localization in human glioblastomas.内源性血管生成素在人胶质母细胞瘤中的表达与定位
J Neuropathol Exp Neurol. 2009 Jun;68(6):633-41. doi: 10.1097/NEN.0b013e3181a52a7f.
5
Serum endocan and preoperative systemic inflammatory markers in patients with epilepsy.癫痫患者的血清内脂素及术前全身炎症标志物
Neurochirurgie. 2020 Feb;66(1):29-35. doi: 10.1016/j.neuchi.2019.09.025. Epub 2019 Oct 18.
6
Elevated Serum Endocan Levels in Patients with Rosacea: A New Therapeutic Target?酒渣鼻患者血清内脂素水平升高:一个新的治疗靶点?
Indian J Dermatol. 2021 Sep-Oct;66(5):520-524. doi: 10.4103/ijd.ijd_401_21.
7
The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis.强直性脊柱炎患者血清内配素水平与抗TNF-α治疗的关系。
Eur J Rheumatol. 2018 Mar;5(1):1-4. doi: 10.5152/eurjrheum.2017.17287.
8
The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial.卡替他汀和内皮糖蛋白与心脏冲击波疗法效果的关联:随机、假手术对照试验的生物标志物子研究
Front Cardiovasc Med. 2023 Feb 23;10:1004574. doi: 10.3389/fcvm.2023.1004574. eCollection 2023.
9
Serum endocan levels in endometrial and ovarian cancers.子宫内膜癌和卵巢癌中的血清内脂素水平。
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22079. Epub 2016 Oct 13.
10
Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.接受有或无体外循环心脏手术患者围手术期内脂素的动力学
Cytokine. 2016 Jul;83:8-12. doi: 10.1016/j.cyto.2016.03.006. Epub 2016 Mar 19.

引用本文的文献

1
Blood endocan as a biomarker for breast cancer recurrence.血液内皮细胞作为乳腺癌复发的生物标志物。
Cancer Biomark. 2024;41(2):145-154. doi: 10.3233/CBM-240034.

本文引用的文献

1
HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.HULC长链非编码RNA沉默通过PI3K/Akt/mTOR信号通路调控ESM-1抑制人胶质瘤血管生成。
Oncotarget. 2016 Mar 22;7(12):14429-40. doi: 10.18632/oncotarget.7418.
2
A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.内皮抑素(ESM-1)与血管内皮细胞标志物(CD34/CD105)在垂体腺瘤侵袭中的表达比较分析
Pituitary. 2016 Apr;19(2):194-201. doi: 10.1007/s11102-015-0698-6.
3
The determination of serum and urinary endocan concentrations in patients with bladder cancer.
膀胱癌患者血清和尿液中内配蛋白浓度的测定。
Ann Clin Biochem. 2016 Nov;53(6):647-653. doi: 10.1177/0004563216629169. Epub 2016 Sep 28.
4
Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.内皮细胞特异性分子-1血清水平与结直肠癌预后
Genet Mol Res. 2015 May 25;14(2):5519-26. doi: 10.4238/2015.May.25.3.
5
Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer.内皮细胞特异性分子-1:一种潜在的胃癌血清标志物。
Tumour Biol. 2014 Oct;35(10):10497-502. doi: 10.1007/s13277-014-2319-9. Epub 2014 Jul 24.
6
Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.血清内皮细胞蛋白 C 受体作为肝细胞癌患者的新型预后生物标志物。
J Cancer. 2014 Mar 4;5(3):221-30. doi: 10.7150/jca.7691. eCollection 2014.
7
Endocan, a new invasion and angiogenesis marker of pituitary adenomas.内皮抑素,一种垂体腺瘤新的侵袭和血管生成标志物。
J Neurooncol. 2014 May;117(3):485-91. doi: 10.1007/s11060-014-1377-6. Epub 2014 Feb 7.
8
Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.癌症中的内脂素:来自一种循环硫酸皮肤素蛋白聚糖的启示。
Int J Cell Biol. 2013;2013:705027. doi: 10.1155/2013/705027. Epub 2013 Mar 28.
9
Endocan expression and localization in human glioblastomas.内源性血管生成素在人胶质母细胞瘤中的表达与定位
J Neuropathol Exp Neurol. 2009 Jun;68(6):633-41. doi: 10.1097/NEN.0b013e3181a52a7f.
10
The 2007 WHO classification of tumours of the central nervous system.2007年世界卫生组织中枢神经系统肿瘤分类
Acta Neuropathol. 2007 Aug;114(2):97-109. doi: 10.1007/s00401-007-0243-4. Epub 2007 Jul 6.